Abbott AV "Diagnostic approach to palpitations." Am Fam Physician 71 (2005): 743-750.
Abdel-Qadir HM, Tu JV, Yun L, Austin PC, Newton GE, Lee DS. Diuretic dose and long-term outcomes in elderly patients with heart failure after hospitalization. American heart journal. Aug 2010;160(2):264-271 e261.
Adams JC, Srivathsan K, Shen WK. Advances in management of premature ventricular contractions. Journal of interventional cardiac electrophysiology: an international journal of arrhythmias and pacing. Nov 2012;35(2):137-149.
al Makdessi S, Sweidan H, Dietz K, Jacob R. Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart. Basic research in cardiology. Apr 1999;94(2):71-77.
Bachman DM "Oral magnesium ion shortens prolonged QTc interval." J Clin Psychiatry 64 (2003): 733-734.
Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure (interim analysis). The CoQ10 Drug Surveillance Investigators. The Clinical investigator. 1993;71(8 Suppl):S145-149.
Barnes BJ and Hollands JM “Drug-induced arrhythmias.” Crit Care Med 38 (2010): S188-197.
Berkova M, Berka Z, Topinkova E. Arrhythmias and ECG changes in life threatening hyperkalemia in older patients treated by potassium sparing drugs. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. Oct 31 2012.
Brouwer IA, Raitt MH, Dullemeijer C, et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. European Heart Journal. 2009;30:820-26.
Brown DA and O'rourke B. "Cardiac mitochondria and arrhythmias." Cardiovasc Res 88 (2010): 241-249.
Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. British journal of clinical pharmacology. 2001;52 Suppl 1:21S-34S.
Cha YM, Lee GK, Klarich KW, et al. Premature Ventricular Contraction-Induced Cardiomyopathy: A Treatable Condition. Circ Arrhythm Electrophysiol. 2012;5:229-36.
Chamberlain AM, Agarwal SK, Folsom AR, et al. "Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study." Heart Rhythm 8 (2011): 1160-1166.
Chang WT, Dao J, Shao ZH. Hawthorn: potential roles in cardiovascular disease. The American journal of Chinese medicine. 2005;33(1):1-10.
Chello M, Mastroroberto P, Romano R, et al. Protection by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting. The Annals of thoracic surgery. Nov 1994;58(5):1427-1432.
Chen Y-R, Yi F-F, Li X-Y, et al. Resveratrol Attenuates Ventricular Arrhythmias and Improves the Long-Term Survival in Rats with Myocardial Infarction. Cardiovasc Drugs Ther. 2008;22:479-85.
Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Progress in cardiovascular diseases. Nov-Dec 2008;51(3):213-228.
Compton SJ, Conrad SA, Setnik G, et al. “Ventricular tachycardia.” Medscape, http://emedicine.medscape.com/article/159075-overview Accessed November 17 2012.
Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. The New England journal of medicine. May 14 2009;360(20):2066-2078.
Cumbee SR, Pryor RE, and Linzer M. “Cardiac loop ECG recording: a new noninvasive diagnostic test in recurrent syncope.” South Med J 83 (1990): 39-43.
Dagres N, Varounis C, Iliodromitis EK, Lekakis JP, Rallidis LS, Anastasiou-Nana M. Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials. American journal of cardiovascular drugs : drugs, devices, and other interventions. Dec 1 2011;11(6):395-400.
D'Alessandro A, Boeckelmann I, Hammwhöner M, et al. “Nicotine, cigarette smoking and cardiac arrhythmia: an overview,” Eur J Prev Cardiol 19 (2012): 297-305.
Davoudi R. Atrial fibrillation. MD Consult: First Consult 2012; Available at: http://www.mdconsult.com/das/pdxmd/body/385623234-2/0?type=med&eid=9-u1.0-_1_mt_1014209#Contributors. Accessed 11/30/2012.
Edvardsson N, Frykman V, van Mechelen R, et al. “Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry.” Europace 13 (2011): 262-269.
Edwards JE, Brown PN, Talent N, Dickinson TA, Shipley PR. A review of the chemistry of the genus Crataegus. Phytochemistry. Jul 2012;79:5-26.
Estes NA, 3rd. Predicting and preventing sudden cardiac death. Circulation. Aug 2 2011;124(5):651-656.
ExitCare 2012. Pacemaker Implantation. Patient Education page. MD Consult Website. Available at: http://www.mdconsult.com/das/patient/body/386861017-2/0/10089/55836.html. Accessed December 4, 2012.
Ezekowitz MD, Nagarakanti R, Lubinski A, et al. A randomized trial of budiodarone in paroxysmal atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. Jun 2012;34(1):1-9.
Falco CN, Grupi C, Sosa E, et al. "Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration." Arq Bras Cardiol (2012): 480-487.
Faulds D, Chrisp P, and Buckley MM “Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.” Drugs 41 (1991): 596-624.
Fazio S, Palmieri EA, Lombardi G, et al. “Effects of thyroid hormone on the cardiovascular system.” Recent Prog Horm Res 59 (2004): 31-50.
Food and Drug Administration (FDA). Drugs @ FDA: FDA approved drug products. Dronedarone hydrochloride. 7/1/2009. Accessed 11/28/2012 at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails
Food and Drug Administration (FDA). Safety: Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events. 12/19/2011. Accessed 11/29/2012 at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm264204.htm
Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Mar 2011;13(3):329-345.
Friedman RA, Kearney DL, Moak JP, et al. “Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults.” J Am Coll Cardiol 24 (1994): 780-783.
Fujioka T, Sakamoto Y, Mimura G. Clinical study of cardiac arrhythmias using a 24-hour continuous electrocardiographic recorder (5th report)--antiarrhythmic action of coenzyme Q10 in diabetics. The Tohoku journal of experimental medicine. Dec 1983;141 Suppl:453-463.
Fuster V, Ryden LE, Cannom DS, et al. "2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines." Circulation 123 (2011): e269-367.
Gallego J, Gil Alzueta MC. [Dabigatran: a new therapeutic alternative in the prevention of stroke]. Neurologia (Barcelona, Spain). Mar 2012;27 Suppl 1:39-45.
Ganjehei L, Massumi A, Nazeri A, Razavi M. Pharmacologic management of arrhythmias. Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital. 2011;38(4):344-349.
Garjani A, Nazemiyeh H, Maleki N, Valizadeh H. Effects of extracts from flowering tops of Crataegus meyeri A. Pojark. on ischaemic arrhythmias in anaesthetized rats. Phytotherapy research : PTR. Sep 2000;14(6):428-431.
Ghuran AV and Camm AJ. Ischaemic heart disease presenting as arrhythmias. Br Med Bull. 2011;59(1):193-210.
Go AS, Hylek EM, Phillips KA, et al. "Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study." JAMA 285 (2001): 2370-2375.
Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC cardiovascular disorders. 2012;12:10.
Guerrera MP, Volpe SL and Mao JJ. "Therapeutic uses of magnesium." Am Fam Physician 80 (2009): 157-162.
Gutierrez C and Blanchard DG. "Atrial fibrillation: diagnosis and treatment." Am Fam Physician 83 (2011): 61-68.
Hansson A, Madsen-Härdig B and Olsson SB. “Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance.” BMC Cardiovasc Disord 4 (2004): 13.
Harling L, Rasoli S, Vecht JA, et al. "Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials." Heart 97 (2011): 1636-1642.
Haugaa KH, Edvardsen T and Amlie JP. "Prediction of life-threatening arrhythmias--still an unresolved problem." Cardiology 118 (2011): 129-137.
Hebbar AK and Hueston WJ. "Management of common arrhythmias: Part I. Supraventricular arrhythmias." Am Fam Physician 65 (2002b): 2479-2486.
Hebbar AK and Hueston WJ. "Management of common arrhythmias: Part II. Ventricular arrhythmias and arrhythmias in special populations." Am Fam Physician 65 (2002a): 2491-2496.
Ho JC, Chang AM, Yan BP, Yu CM, Lam YY, Lee VW. Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong. Clinical cardiology. Oct 25 2012.
Homoud M. Tufts-New England Medical Center: Introduction to Antiarrhythmic Agents. 2008; http://ocw.tufts.edu/data/50/636944.pdf. Accessed 11/27/2012.
Hung LM, Su MJ and Chen JK. “Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms.” Free Radic Biol Med 36 (2004): 774-781.
Jaeger FJ. Cardiac Arrhythmias. Cleveland Clinic: Center for Continuing Education. Available at: www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiac-arrhythmias/. 8/1/2010.
Jayaprasad N and Johnson F. “Atrial fibrillation and hyperthyroidism.” Indian Pacing and Electrophysiology Journal 5 (2005): 305–311.
Jenkins DJA, Josse AR, Beyene J, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ. 2008;178(2): 157-64.
Jeong EM, Liu M, Sturdy M, Gao G, Varghese ST, Sovari AA, Dudley SC, Jr. Metabolic stress, reactive oxygen species, and arrhythmia. Journal of molecular and cellular cardiology. Feb 2012;52(2):454-463.
Ji S, Cesario D, Valderrabano M, et al. “The molecular basis of cardiac arrhythmias in patients with cardiomyopathy.” Curr Heart Fail Rep 1 (2004): 98-103.
Johns Hopkins Medicine. Congestive Heart Failure. Available at: http://www.hopkinsmedicine.org/heart_vascular_institute/conditions_treatments/conditions/congestive_heart_failure.html? INEDITMODE=Yes&currpage=1&pageCount=10. Accessed December 4, 2012.
Joseph JP and Rajappan K. "Radiofrequency ablation of cardiac arrhythmias: past, present and future." QJM 105 (2012): 303-314.
Katz AM. Cardiac arrhythmias. The American journal of physiology. Dec 1999;277(6 Pt 2):S214-233.
Knecht S, Wilton SB and Haissaguerre M "The 2010 update of the ESC guidelines for the management of atrial fibrillation." Circ J 74 (2010): 2534-2537.
Kodama S, Saito K, Tanaka S, et al. "Alcohol consumption and risk of atrial fibrillation: a meta-analysis." J Am Coll Cardiol 57 (2011): 427-436.
Konofagou EE, Luo J, Saluja D, et al. "Noninvasive electromechanical wave imaging and conduction-relevant velocity estimation in vivo." Ultrasonics 50 (2010): 208-215.
Konofagou EE, Provost J. Electromechanical wave imaging for noninvasive mapping of the 3D electrical activation sequence in canines and humans in vivo. Journal of biomechanics. Mar 15 2012;45(5):856-864.
Korantzopoulos P, Kolettis TM, Kountouris E, et al. "Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation." Int J Cardiol 102 (2005): 321-326.
Kromhout D, Geleijnse JM, De Goede J, et al. "n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes." Diabetes Care 34 (2011): 2515-2520.
Lavie CJ, Milani RV, Mehra MR, et al. "Omega-3 polyunsaturated fatty acids and cardiovascular diseases." J Am Coll Cardiol 54 (2009): 585-594.
Lee GK, Klarich KW, Grogan M, et al. "Premature ventricular contraction-induced cardiomyopathy: a treatable condition." Circ Arrhythm Electrophysiol 5 (2012): 229-236.
Link MS. Clinical practice. Evaluation and initial treatment of supraventricular tachycardia. The New England journal of medicine. Oct 11 2012;367(15):1438-1448.
Lomuscio A, Belletti S, Battezzati PM, Lombardi F. Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion. Journal of cardiovascular electrophysiology. Mar 2011;22(3):241-247.
Magri D, Piccirillo G, Quaglione R, et al. "Effect of Acute Mental Stress on Heart Rate and QT Variability in Postmyocardial Infarction Patients." ISRN Cardiol 2012 (2012): 912672.
Maimeskulova LA and Maslov LN. "[Anti-arrhythmic effect of phytoadaptogens]." Eksp Klin Farmakol 63 (2000): 29-31.
Maisel WH. Autonomic modulation preceding the onset of atrial fibrillation. J Am Coll Cardiol. 2003;42(7):1269-70.
Marik PE and Varon J. "Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review." Clin Cardiol 32 (2009): 365-372.
Martin A and Stewart R. "Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation." Clin Med Insights Cardiol 6 (2012): 103-109.
Maseeh uz Z, Fatima N, Sajjad Z. Amiodarone therapy: don't forget thyroid. JPMA. The Journal of the Pakistan Medical Association. Mar 2012;62(3):268-272.
Maslov LN, Lishmanov YB, Arbuzov AG, et al. "Antiarrhythmic activity of phytoadaptogens in short-term ischemia-reperfusion of the heart and postinfarction cardiosclerosis." Bull Exp Biol Med 147 (2009): 331-334.
Mason PK, DiMarco JP. New pharmacological agents for arrhythmias. Circulation. Arrhythmia and electrophysiology. Oct 2009;2(5):588-597.
Mathew B, Francis L, Kayalar A, et al. “Obesity: effects on cardiovascular disease and its diagnosis.“ J Am Board Fam Med 21 (2008): 562-568.
Mattioli AV, Bonatti S, Zennaro M, et al. "Effect of coffee consumption, lifestyle and acute life stress in the development of acute lone atrial fibrillation." J Cardiovasc Med (Hagerstown) 9 (2008): 794-798.
Mattioli AV, Miloro C, Pennella S, et al. "Adherence to Mediterranean diet and intake of antioxidants influence spontaneous conversion of atrial fibrillation." Nutr Metab Cardiovasc Dis. 2011 Jul 26. [Epub ahead of print]
Maury P, Chilon T, Dumonteil N, et al. “Complete atrioventricular block persisting after regression of infectious myocarditis.” J Electrocardiol 41 (2008): 665-667.
Mayo Clinic. Heart arrhythmias. Definition. Available at: http://www.mayoclinic.com/health/heart-arrhythmias/DS00290. Last updated Feb 11, 2011a. Accessed June 26, 2012.
Mayo Clinic. Heart arrhythmias. Risk factors. Available at: http://www.mayoclinic.com/health/heart-arrhythmias/DS00290/DSECTION=risk-factors. Last updated February 11, 2011d. Accessed December 4, 2012.
Mayo Clinic. Heart arrhytmias. Causes. Available at: http://www.mayoclinic.com/health/heart-arrhythmias/DS00290/DSECTION=causes. Last updated February 11, 2011c. Accessed December 4, 2012.
Mayo Clinic. Premature ventricular contractions (PVCs). Available at: http://www.mayoclinic.com/health/premature-ventricular-contractions/DS00949/DSECTION=risk-factors. Last udpated May 24, 2011b. Accessed December 4, 2012.
Merck Manual webpage. Acute Coronary Syndromes (Heart Attack; Myocardial Infarction; Unstable Angina). Available at: http://www.merckmanuals.com/home/heart_and_blood_vessel_disorders/ coronary_artery_disease/acute_coronary_syndromes_heart_attack_myocardial_infarction_unstable_angina.html. Last updated February 2008. Accessed December 4, 2012.
Merriam-Webster. Tacchyarrhythmia. Avialable at: http://www.merriam-webster.com/dictionary/tachyarrhythmia . Accessed 12/5/2012.
Morey TE, Seubert CN, Raatikainen MJ, et al. Structure-activity relationships and electrophysiological effects of short-acting amiodarone homologs in guinea pig isolated heart. The Journal of pharmacology and experimental therapeutics. Apr 2001;297(1):260-266.
Nagai S, Miyazaki Y, Ogawa K, Satake T, Sugiyama S, Ozawa T. The effect of Coenzyme Q10 on reperfusion injury in canine myocardium. Journal of molecular and cellular cardiology. Sep 1985;17(9):873-884.
Nakamura Y, Kiaii B and Chu MW "Minimally invasive surgical therapies for atrial fibrillation." ISRN Cardiol 2012 (2012): 606324.
Narayan SM, Krummen DE, Shivkumar K, et al. "Treatment of Atrial Fibrillation by the Ablation of Localized Sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) Trial." J Am Coll Cardiol. 2012;60(7): 628-36.
Narumiya T, Sakamaki T, Sato Y, et al. "Relationship between left atrial appendage function and left atrial thrombus in patients with nonvalvular chronic atrial fibrillation and atrial flutter." Circ J 67 (2003): 68-72.
National Center for Complementary and Alternative Medicine (NCCAM). Acupuncture. Available at: http://nccam.nih.gov/sites/nccam.nih.gov/files/D404_BKG.pdf. Last updated August, 2011. Accessed 09/06/2012.
National Heart Lung and Blood Institute. What are palpitations? Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/hpl/. Last updated July 1, 2011c. Accessed December 4, 2012.
National Heart Lung and Blood Institute. What is an arrhythmia? Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/arr/. Last updated July 1, 2011a. Accessed 06/26/2012.
National Heart Lung and Blood Institute. What is the heart? Available at: http://www.nhlbi.nih.gov/health/health-topics/topics/hhw/. Last updated Nov 17, 2011b. Accessed 06/26/2012.
National Institutes of Health. Heart Palpitations. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/003081.htm. Last updated 03 June, 2012c. Accessed 09/17/2012.
National Institutes of Health. Paroxysmal supraventricular tachycardia (PSVT). Available at: http://www.nlm.nih.gov/medlineplus/ency/article/000183.htm. Last updated 27 July, 2012b. Accessed 06/26/2012.
Nauman J, Nilsen TI, Wisloff U, Vatten LJ. Combined effect of resting heart rate and physical activity on ischaemic heart disease: mortality follow-up in a population study (the HUNT study, Norway). Journal of epidemiology and community health. Feb 2010;64(2):175-181.
Nava A, Thiene G, Canciani B, et al. “Clinical profile of concealed form of arrhythmogenic right ventricular cardiomyopathy presenting with apparently idiopathic ventricular arrhythmias.” Int J Cardiol 35 (1992): 195-206.
Nessler J, Nessler B, Kitliński M, et al. Sudden cardiac death risk factors in patients with heart failure treated with carvedilol. Kardiol Pol. 2007;65(12):1417-22; discussion 1423-4.
Ozaydin M, Peker O, Erdogan D, et al. "N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study." Eur Heart J 29 (2008): 625-631.
Park SK, Tucker KL, O'neill MS, et al. "Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study." Am J Clin Nutr 89 (2009): 778-786.
Parry SW and Matthews IG. “Implantable loop recorders in the investigation of unexplained syncope: a state of the art review.�� Heart 96 (2010): 1611-1616.
Patterson E and Scherlag BJ. “Decremental conduction in the posterior and anterior AV nodal inputs.” J Interv Card Electrophysiol 7 (2002): 137-148.
Pepe M and Recchia FA. "Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias." Cardiovasc Ther 28 (2010): e1-4.
Piccini JP, White JA, Mehta RH, et al. “Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.” Circulation 126 (2012): 41-49.
Podrid PJ, Lampert S, Graboys TB, et al. “Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.” Am J Cardiol 59 (1987): 38E-44E.
Prasad V, Kaplan RM and Passman RS. “New frontiers for stroke prevention in atrial fibrillation.” Cerebrovasc Dis 33(2012): 199-208.
Provost J, Lee WN, Fujikura K, et al. "Imaging the electromechanical activity of the heart in vivo." Proc Natl Acad Sci U S A 108 (2011a): 8565-8570.
Provost J, Nguyen VT, Legrand D, et al.” Electromechanical wave imaging for arrhythmias.” Phys Med Biol 56 (2011b): L1-11.
Rasoli S, Kakouros N, Harling L, et al. "Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence?" Cardiol Res Pract 2011 (2011): 164078.
Raviele A, Giada F, Bergfeldt L, et al. “Management of patients with palpitations: a position paper from the European Heart Rhythm Association.” EP Europace (2011): 920-934.
Rekawek J, Kansy A, Miszczak-Knecht M, et al. “Risk factors for cardiac arrhythmias in children with congenital heart disease after surgical intervention in the early postoperative period.” J Thorac Cardiovasc Surg 133 (2007): 900-904.
Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. Mar 1 2002;59(5):417-422.
Roberts-Thomson KC, Lau DH and Sanders P. "The diagnosis and management of ventricular arrhythmias." Nat Rev Cardiol 8 (2011): 311-321.
Rodrigo R, Vinay J, Castillo R, et al. "Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation." Int J Cardiol 138 (2010): 221-228.
Sali A and Vitetta L. "Integrative medicine and arrhythmias." Aust Fam Physician 36 (2007): 527-528.
Sanguinetti MC and Bennett PB. “Antiarrhythmic drug target choices and screening.” Circ Res 93 (2003): 491-499.
Schmidt C, Kisselbach J, Schweizer PA, et al. "The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation." Vasc Health Risk Manag 7 (2011): 193-202.
Schwartz NE, Albers GW. Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation. Stroke; a journal of cerebral circulation. Jun 2010;41(6):1307-1309.
Shea JB and Sears SF. "Cardiology patient pages. A patient's guide to living with atrial fibrillation." Circulation 117 (2008): e340-343.
Siddoway LA. Amiodarone: guidelines for use and monitoring. American family physician. Dec 1 2003;68(11):2189-2196.
Singh BN, Singh SN, Reda DJ, et al. Amiodarone versus sotalol for atrial fibrillation. The New England journal of medicine. May 5 2005;352(18):1861-1872.
Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. Sep 1998;12(4):347-353.
Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure. Nutrition reviews. Jun 2007;65(6 Pt 1):286-293.
Sorokin AV, Araujo CG, Zweibel S, et al. “Atrial fibrillation in endurance-trained athletes.” Br J Sports Med 45 (2011): 185-188.
Sucu M, Davutoglu V, Ozer O. Electrical cardioversion. Annals of Saudi medicine. May-Jun 2009;29(3):201-206.
Sultan A, Steven D, Rostock T, et al. "Intravenous administration of magnesium and potassium solution lowers energy levels and increases success rates electrically cardioverting atrial fibrillation." J Cardiovasc Electrophysiol 23 (2012): 54-59.
Tadic VM, Dobric S, Markovic GM, Dordevic SM, Arsic IA, Menkovic NR, Stevic T. Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. Journal of agricultural and food chemistry. Sep 10 2008;56(17):7700-7709.
Taggart P, Boyett MR, Logantha S, et al. “Anger, emotion, and arrhythmias: from brain to heart.” Front Physiol 2 (2011): 67.
Tauchert M, Gildor A, Lipinski J. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure]. Herz. Oct 1999;24(6):465-474; discussion 475.
Tedrow UB, Conen D, Ridker PM, et al. "The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)." J Am Coll Cardiol 55 (2010): 2319-2327.
Tung R. Sudden cardiac death in adults. First Consult 2012; http://www.mdconsult.com/das/pdxmd/body/383775433-3/1383037726?type=med&eid=9-u1.0-_1_mt_5082605#Contributors. Accessed 11/21/2012.
Turagam MK, Velagapudi P and Kocheril AG “Atrial fibrillation in athletes.” Am J Cardiol 109 (2012): 296-302.
UoMMC. University of Maryland Medical Center. . Maryland Heart Center, Patient Conditions: Arrhythmias 2012; http://www.umm.edu/heart/arrhythmias/index.htm. Accessed 11/20/2012.
Van Herendael H, Dorian P. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vascular health and risk management. 2010;6:465-472.
Van Mieghem W, Mairesse G, Missault L, et al. "Stroke prevention in atrial fibrillation: current status and emerging therapies." Acta Cardiol 67 (2012): 161-167.
Vanwormer AM, Lindquist R and Sendelbach SE. "The effects of acupuncture on cardiac arrhythmias: a literature review." Heart Lung 37 (2008): 425-431.
Vlay SC. "The ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: their relevance to the cardiologist, internist and family physician." J Invasive Cardiol 21 (2009): 234-237.
Weant KA, Smith KM. The role of coenzyme Q10 in heart failure. The Annals of pharmacotherapy. Sep 2005;39(9):1522-1526.
Web MD. Heart Palpitations. Available at: http://www.webmd.com/heart-disease/guide/what-causes-heart-palpitations. Last updated 29 June, 2011. Accessed 09/17/2012.
Weirich J, Wenzel W. [Current classification of anti-arrhythmia agents]. Zeitschrift fur Kardiologie. 2000;89 Suppl 3:62-67.
Wit AL and Boyden PA. “Triggered activity and atrial fibrillation.” Heart Rhythm 4 (2007): S17-23.
Witchel HJ, Hancox JC and Nutt DJ. “Psychotropic drugs, cardiac arrhythmia, and sudden death.” J Clin Psychopharmacol 23 (2003): 58-77.
Wolin MS and Gupte SA. “Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function.” Circ Res 97 (2005): 612-614.
Wu JH, Lemaitre RN, King IB, et al. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012 Mar;125(9):1084-93.
Wu T, Zhou H, Jin Z, et al. "Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins." Eur J Pharmacol 613 (2009): 93-99.
Xin P, Pan Y, Zhu W, et al. “Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.” Eur J Pharmacol 649 (2010): 293-300.
You JJ, Singer DE, Howard PA, et al. "Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest 141 (2012): e531S-575S.
Zaza A. Serum potassium and arrhythmias. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. Apr 2009;11(4):421-422.
Ziegelstein RC. “Acute emotional stress and cardiac arrhythmias.” JAMA 298 (2007): 324-329.